O
STJ

OppenheimerFunds’s St Jude Medical STJ Stock Holding History

OppenheimerFunds’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,170
Closed -$655K – 1943
2016
Q4 		$655K Buy
8,170
+1,094
+15% +$86.8K ﹤0.01% 1249
2016
Q3 		$564K Buy
7,076
+741
+12% +$59.8K ﹤0.01% 1204
2016
Q2 		$494K Sell
6,335
-2,001,771
-100% -$143M ﹤0.01% 1246
2016
Q1 		$110M Buy
2,008,106
+153,501
+8% +$8.36M 0.15% 169
2015
Q4 		$115M Buy
1,854,605
+16,835
+0.9% +$1.06M 0.15% 165
2015
Q3 		$116M Sell
1,837,770
-41,670
-2% -$2.97M 0.16% 160
2015
Q2 		$137M Buy
1,879,440
+24,440
+1% +$1.77M 0.16% 164
2015
Q1 		$121M Buy
1,855,000
+3,770
+0.2% +$251K 0.14% 191
2014
Q4 		$120M Buy
1,851,230
+4,890
+0.3% +$315K 0.13% 190
2014
Q3 		$111M Buy
1,846,340
+7,570
+0.4% +$495K 0.12% 197
2014
Q2 		$127M Buy
1,838,770
+41,600
+2% +$2.7M 0.14% 184
2014
Q1 		$118M Sell
1,797,170
-14,820
-0.8% -$965K 0.14% 183
2013
Q4 		$112M Sell
1,811,990
-10,160
-0.6% -$588K 0.14% 191
2013
Q3 		$97.7M Sell
1,822,150
-12,250
-0.7% -$631K 0.13% 203
2013
Q2 		$83.7M Buy
+1,834,400
New +$79.5M 0.12% 212

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

OppenheimerFunds's STJ Position: Q1 2017 in Review

OppenheimerFunds sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,170 shares — an estimated $655K sold.

OppenheimerFunds first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $137M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • OppenheimerFunds reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • OppenheimerFunds sold 8,170 St Jude Medical shares in Q1 2017, an estimated $655K.
  • OppenheimerFunds first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • OppenheimerFunds's St Jude Medical position peaked at $137M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on OppenheimerFunds's 13F filing for Q1 2017, filed 11 May 2017.